Could a 6-Month pill combo beat standard TB treatment?
NCT ID NCT07198685
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 29 times
Summary
This study compares a 6-month all-oral drug regimen (bedaquiline, delamanid, linezolid, levofloxacin) to the standard long-course treatment for people with rifampin-resistant tuberculosis. About 52 adults in China will take either the short or standard regimen. The goal is to see if the shorter treatment works just as well and is safe enough to replace the longer one.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TREAT TO TARGET are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.